Lataa...
Regadenoson, a Novel Pharmacologic Stress Agent for Use in Myocardial Perfusion Imaging, Does Not Have a Direct Effect on the QT Interval in Conscious Dogs
Our goal was to determine the effect of regadenoson (a novel A(2A) adenosine receptor agonist) on the QT interval in conscious dogs. Eleven mongrel dogs were chronically instrumented for measurements of blood pressure and ECG. Regadenoson (2.5, 5 and 10 μg/kg, IV) caused a dose-dependent QT interval...
Tallennettuna:
| Julkaisussa: | J Cardiovasc Pharmacol |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5774219/ https://ncbi.nlm.nih.gov/pubmed/19033827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0b013e31818e035b |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|